Literature DB >> 11044780

Fate of patients with questionable (very mild) Alzheimer's disease: longitudinal profiles of individual subjects' decline.

R J Perry1, J R Hodges.   

Abstract

Currently used criteria for the diagnosis of probable Alzheimer's disease requires the presence of cognitive deficit in addition to loss of episodic memory. The recent developments in drug treatments for Alzheimer's disease have highlighted the importance of early diagnosis and the need to characterise the cognitive profile of the earliest stages of the disease. We set out to examine the pattern of decline in terms of individual cognitive domains in non-demented subjects with clinically isolated progressive amnesia which we have termed questionable Alzheimer's disease. Twelve subjects who fulfill criteria for a clinical diagnosis of possible Alzheimer's disease by NINCDS-ADRDA criteria were compared to 20 age-matched controls in a longitudinal study. All subjects had MMSE scores of 24 or greater at entry to study. Individual profiles were measured by impairment in the cognitive domains of episodic memory, attention, semantic memory, visuospatial function and auditory verbal short-term (working) memory. Even after subjects were given this intensive neuropsychological battery, 8 of 12 subjects had episodic memory deficits only. Within 12 months just 3 patients were only amnesic and the other patients with pure amnesia at year 1 developed either semantic or attentional deficits. Impairment in both these cognitive domains preceded impairment in visuospatial function and auditory-verbal short-term memory. Our findings are consistent with the pattern of cognitive impairment in Alzheimer's disease increasing in accordance with neuropathological correlates of cognitive function with amnesia linked to the initial medial temporal pathology before the pattern of spread affects critical neural substrates for attention and semantic memory. Tests of selective attention and semantic memory appear to be the most sensitive markers of decline beyond the amnestic phase of early Alzheimer's disease. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 11044780     DOI: 10.1159/000017264

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  8 in total

Review 1.  Evolution of the diagnostic criteria for degenerative and cognitive disorders.

Authors:  Oscar L Lopez; Eric McDade; Mario Riverol; James T Becker
Journal:  Curr Opin Neurol       Date:  2011-12       Impact factor: 5.710

2.  Altered Gray Matter Structural Covariance Networks in Early Stages of Alzheimer's Disease.

Authors:  Maxime Montembeault; Isabelle Rouleau; Jean-Sébastien Provost; Simona Maria Brambati
Journal:  Cereb Cortex       Date:  2015-05-20       Impact factor: 5.357

3.  Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys.

Authors:  Michael A Taffe; Michael R Weed; Tannia Gutierrez; Sophia A Davis; Lisa H Gold
Journal:  Psychopharmacology (Berl)       Date:  2002-01-22       Impact factor: 4.530

4.  PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.

Authors:  Ahmadul Kadir; Ove Almkvist; Anders Wall; Bengt Långström; Agneta Nordberg
Journal:  Psychopharmacology (Berl)       Date:  2006-07-11       Impact factor: 4.530

5.  Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease.

Authors:  Cheryl L Grady; Anthony R McIntosh; Sania Beig; Michelle L Keightley; Hana Burian; Sandra E Black
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

Review 6.  Early detection of memory impairment in Alzheimer's disease: a neurocognitive perspective on assessment.

Authors:  Georgia Lowndes; Greg Savage
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

7.  Verbal episodic memory and endogenous estradiol: an association in patients with mild cognitive impairment and Alzheimer's disease.

Authors:  D M Bittner; V Bittner; M W Riepe
Journal:  Curr Gerontol Geriatr Res       Date:  2011-12-19

8.  Hippocampal Injections of Oligomeric Amyloid β-peptide (1-42) Induce Selective Working Memory Deficits and Long-lasting Alterations of ERK Signaling Pathway.

Authors:  Pierre Faucher; Nicole Mons; Jacques Micheau; Caroline Louis; Daniel J Beracochea
Journal:  Front Aging Neurosci       Date:  2016-01-11       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.